Mortara Instrument Establishes New Executive Structure

September 25, 2008

Company announces appointment of Dr. Justin L. Mortara to Chief Executive Officer

Company announces appointment of Dr. Justin L. Mortara to Chief Executive Officer

Milwaukee, September 25, 2008-  Today Mortara Instrument announced the appointment of Dr. Justin L. Mortara to the position of Chief Executive Officer with responsibility for all executive leadership and associated functional areas. Under this new structure, Mortara Instrument's founder, Dr. David W. Mortara, will continue to serve as President with an increased focus on new technology development and strategic initiatives for the company.

Dr. Justin Mortara is the second generation of the Mortara family to lead Mortara Instrument. Founded in 1982, the company today employs over 200 people worldwide and has annual revenues in excess of $50 million. Dr. Mortara most recently served as Vice President and previously served in a variety of roles within the company since 1998. He is the author of various publications and presentations related to ECG technology and algorithms, in particular their application to the evaluation of the cardiac safety of new drugs. Prior to joining Mortara Instrument, Dr. Mortara was employed as a Research Fellow at Lawrence Berkeley National Laboratory in Berkeley, California. He received his doctorate in physics from the University of California at Berkeley, and his undergraduate degree from the University of Chicago.

Dr. David Mortara, President of Mortara Instrument, commented, "Since our earliest days as a company, Justin has been involved in our business. Over the last ten years, we have achieved substantial growth and continued to realize our goal of designing products to a need, keeping them simple and making them economically accessible. I am confident Justin will continue to lead us in this vein as Mortara looks ahead to its next 25 years."

Mortara Instrument, based in Milwaukee, has subsidiaries located in Australia, Germany, Italy and the Netherlands and markets it products worldwide. Its portfolio of non-invasive diagnostic cardiology products include resting electrocardiographs, cardiac stress exercise systems and Holter monitors. Mortara's products are used in both clinics and hospitals as well as in pharmaceutical trials requiring collection of ECG recordings. The company is one of the fastest growing in its sector and is a leading supplier of ECG systems to the U.S. government including contracts with both the FAA and FDA for the evaluation of commercial pilot flight readiness and the cardiac safety of new drugs respectively.

Dr. Justin Mortara noted, "Mortara Instrument has enjoyed impressive organic growth over the last several years. Thanks to the leadership of my father and the dedication of our employees, we are well positioned to continue this growth as we expand in the U.S. and other markets abroad. I look forward to working alongside him and as we continue to grow and broaden our impact on healthcare worldwide."